STORY FROM: Drugs & Medical Devices

Zostavax Shingles Vaccine Case Time-Barred, 3rd Cir. Affirms

PHILADELPHIA — A lawsuit in which an Indiana man alleges Merck’s anti-shingles vaccine Zostavax left him with permanent lung damage is time-barred because he was aware early on that the vaccine could have caused his injuries, yet waited to file suit until after the limitations period had expired, a federal appeals court has affirmed.

On April 4, the 3rd Circuit U.S. Court of Appeals further agreed with the trial court that there is no evidence that Merck & Company Inc. fraudulently concealed the vaccine’s risks from the plaintiff’s doctor, and therefore the limitations period was not tolled.

Chris Juday became ...

Associated Law Firms
Bern Cappelli
Fox Rothschild
Lopez McHugh
Venable

Associated Documents
Opinion



Registered User Login

Username

Password

True